Quarterly Consolidated Statement Of Cash Flows

COSMO BIO COMPANY, LIMITED - Filing #7571611

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
610,000,000 JPY
790,000,000 JPY
1,148,000,000 JPY
1,099,000,000 JPY
Depreciation
141,000,000 JPY
166,000,000 JPY
Increase (decrease) in allowance for doubtful accounts
-5,000,000 JPY
0 JPY
Interest and dividend income
-45,000,000 JPY
-41,000,000 JPY
Interest expenses
0 JPY
0 JPY
Decrease (increase) in trade receivables
-73,000,000 JPY
75,000,000 JPY
Decrease (increase) in inventories
-267,000,000 JPY
-245,000,000 JPY
Increase (decrease) in trade payables
0 JPY
75,000,000 JPY
Other, net
-6,000,000 JPY
-121,000,000 JPY
Subtotal
519,000,000 JPY
990,000,000 JPY
Interest and dividends received
44,000,000 JPY
41,000,000 JPY
Interest paid
0 JPY
0 JPY
Net cash provided by (used in) operating activities
284,000,000 JPY
648,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-55,000,000 JPY
-31,000,000 JPY
Purchase of investment securities
-502,000,000 JPY
-100,000,000 JPY
Other, net
9,000,000 JPY
11,000,000 JPY
Net cash provided by (used in) investing activities
-291,000,000 JPY
-145,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
JPY
-194,000,000 JPY
Dividends paid
-232,000,000 JPY
-223,000,000 JPY
Dividends paid to non-controlling interests
-2,000,000 JPY
-2,000,000 JPY
Other, net
-1,000,000 JPY
0 JPY
Net cash provided by (used in) financing activities
-236,000,000 JPY
-420,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
24,000,000 JPY
12,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-218,000,000 JPY
95,000,000 JPY
Cash and cash equivalents
3,036,000,000 JPY
3,255,000,000 JPY
3,159,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.